From standard textbooks ยท RGUHS Practical Notes
The two iris muscles, ciliary muscle, and the visual pathway
| Muscle | Fibre Type | Receptor & System | Contraction Effect |
|---|---|---|---|
| Sphincter Pupillae | Circular (ring-shaped around pupil) | M3 Muscarinic (Parasympathetic) โ activated by acetylcholine | Pupil gets SMALLER โ MIOSIS |
| Dilator Pupillae | Radial (spoke-like, pupil outward) | ฮฑ1 Adrenergic (Sympathetic) โ activated by noradrenaline/adrenaline | Pupil gets BIGGER โ MYDRIASIS |
| Ciliary Muscle | Smooth muscle around the lens | M3 Muscarinic (Parasympathetic) | Contraction โ lens becomes CONVEX โ near vision (accommodation). Paralysis โ cycloplegia |
Active vs passive mydriasis โ the critical distinction for the exam
| Term | Definition & Mechanism |
|---|---|
| MIOTICS | Drugs that CONSTRICT the pupil (cause MIOSIS). Mechanism: Contraction of sphincter pupillae via M3 muscarinic (parasympathetic) activation. |
| MYDRIATICS | Drugs that DILATE the pupil (cause MYDRIASIS). Two mechanisms: (1) Active โ ฮฑ1 stimulation of dilator pupillae. (2) Passive โ M3 blockade of sphincter pupillae. |
| Type | Mechanism | Drugs | Light Reflex |
|---|---|---|---|
| Active Mydriasis | Sympathomimetics stimulate ฮฑ1 adrenergic receptors on dilator pupillae โ muscle CONTRACTS โ pupil dilates | Phenylephrine, Ephedrine, Adrenaline | PRESERVED โ sphincter intact |
| Passive Mydriasis | Anticholinergics block M3 receptors on sphincter pupillae โ muscle CANNOT CONTRACT โ pupil dilates passively | Atropine, Tropicamide, Hyoscine | ABOLISHED โ sphincter's neural drive is blocked |
All drugs with mechanism, concentration, and key features
Miotics
| Drug (Concentration) | Mechanism | Effects & Uses |
|---|---|---|
| Pilocarpine (0.5โ4%) | Direct M3 agonist. Naturally occurring alkaloid from Pilocarpus plant. | Miosis in 10 min, lasts ~4 hrs. Lowers IOP. Used in glaucoma (both types). Improves near vision, blurs distant. |
| Physostigmine (1โ2%) | Reversible anticholinesterase (indirect). Inhibits AChE โ ACh builds up โ stimulates M3. | Miosis + ciliary spasm. Also used in glaucoma. Absorbed locally to produce miosis. |
| Carbachol | Direct cholinergic agonist (both muscarinic + nicotinic). | Miosis and decreased IOP. |
Mydriatics โ A. Anticholinergic (Passive Mydriasis + Cycloplegia)
| Drug | Mechanism | Duration | Key Clinical Notes |
|---|---|---|---|
| Atropine (1%) | Competitive M3 antagonist. Blocks sphincter pupillae AND ciliary muscle. | 7โ14 days | Mydriasis + CYCLOPLEGIA. Light reflex ABOLISHED. Contraindicated in glaucoma. Raises IOP. |
| Homatropine (0.5โ2%) | Shorter-acting M3 blocker. | 24โ48 hours | Mydriasis + cycloplegia. Used for fundoscopy. |
| Tropicamide (1%) | Short-acting antimuscarinic. M3 blocker. | 4โ8 hours | PREFERRED for routine fundoscopy/refraction. Onset 15โ30 min. Avoid soft contact lenses after use. |
| Hyoscine / Scopolamine | Competitive M1 antagonist. Anticholinergic alkaloid. | ~6 hours | Mydriasis + cycloplegia. Reduces salivation, increases HR. Max effect at ~3 hours. Motion sickness. |
| Cyclopentolate | Anticholinergic. | Shorter than atropine | Mydriasis + cycloplegia. Used for refraction testing. |
Mydriatics โ B. Sympathomimetic (Active Mydriasis โ NO Cycloplegia)
| Drug | Mechanism | Key Clinical Notes |
|---|---|---|
| Phenylephrine (2.5โ10%) | Direct ฮฑ1 adrenergic agonist. Stimulates dilator pupillae. | Mydriasis WITHOUT cycloplegia. Light reflex PRESERVED. Used for fundoscopy. |
| Ephedrine (5%) | Indirect sympathomimetic. Releases stored noradrenaline. | Mydriasis. Light AND corneal reflexes preserved. |
| Adrenaline (0.1%) | Direct ฮฑ1 and ฮฒ2 agonist. | Mydriasis. Also reduces IOP by decreasing aqueous humor production (ฮฒ2 on ciliary epithelium). |
| Cocaine (1%) | Local anaesthetic + indirect sympathomimetic (blocks NA reuptake โ more NA at ฮฑ1). | Mydriasis + LOSS OF CORNEAL REFLEX (local anaesthetic). Light reflex preserved. UNIQUE profile. |
Procedure, parameters, precautions, and expected results
Drugs Used
| Drug Type | Examples |
|---|---|
| Miotics | Pilocarpine 0.5โ4%, Physostigmine 1โ2% |
| Sympathomimetic Mydriatics | Adrenaline 0.1%, Phenylephrine 2.5โ10%, Ephedrine 5% |
| Anticholinergic Mydriatics | Atropine 1%, Homatropine 0.5% |
| Special (Local Anaesthetic) | Cocaine 1% |
| Control | Normal Saline |
Weigh and mark the rabbits. Select 3 rabbits: one each for pupil, corneal, and light reflex testing.
Restrain in restrainer with head protruding. Acclimatise for 5 minutes to reduce stress-related pupil changes.
Mark one eye as Test Eye (TE) and the other as Control Eye (CE). Trim eyelashes of both eyes with scissors.
Instil normal saline into BOTH eyes to clean and establish baseline (control) reading.
Instil test drug into the TEST EYE ONLY (2โ3 drops; 40โ60 ฮผl). Control eye remains untreated.
After 5 minutes, measure and record all four parameters in both eyes.
| # | Parameter | How Tested | Normal Response |
|---|---|---|---|
| 1 | Pupil Size | Measured with pupillometer; compared to control eye and baseline | Baseline pupil diameter |
| 2 | Light Reflex | Shine torch at pupil | Pupil CONSTRICTS. Absent = sphincter pupillae blocked (anticholinergic) |
| 3 | Corneal Reflex | Touch cornea at corneoscleral junction with cotton tip brought from the SIDE | Rabbit CLOSES the eye. Absent = cornea anaesthetised (local anaesthetic) |
| 4 | Condition of Conjunctiva | Visual inspection | Normally thin and clear. Hyperaemia/redness noted if drug causes irritation. |
| Drug | Pupil | Light Reflex | Corneal Reflex | Mechanism |
|---|---|---|---|---|
| Saline (Control) | Normal | Present | Present | No drug effect |
| Pilocarpine / Physostigmine | CONSTRICTION | Present | Present | M3 activation โ sphincter contracts |
| Atropine | DILATION | ABSENT โ | Present | M3 block โ sphincter paralysed (passive mydriasis + cycloplegia) |
| Phenylephrine | DILATION | Present | Present | ฮฑ1 stimulation โ dilator contracts (active mydriasis) |
| Ephedrine | DILATION | Present | Present | Indirect sympathomimetic โ ฮฑ1 activation |
| Cocaine | DILATION | Present | ABSENT โ | NA reuptake block (mydriasis) + local anaesthetic (corneal reflex lost) |
| Adrenaline | DILATION | Present | Present | ฮฑ1 direct activation โ dilator muscle |
Deep-dive on each drug โ mechanism, effects, clinical uses, ADRs, viva answers
| Feature | Detail |
|---|---|
| Source | Naturally occurring alkaloid from leaves of Pilocarpus plant |
| Mechanism on eye | M3 stimulation โ (1) Sphincter pupillae โ MIOSIS; (2) Ciliary muscle โ near vision accommodation; (3) โ aqueous outflow through trabecular meshwork โ โ IOP |
| Onset of miosis | 10 minutes after instillation |
| Duration | ~4 hours |
| Effect on vision | Near vision IMPROVES. Distant vision is BLURRED. |
| Effect on IOP | DECREASES IOP โ increases aqueous outflow |
| Clinical uses | 1. Chronic open-angle glaucoma. 2. Acute angle-closure glaucoma (emergency). 3. Antidote for atropine/hyoscine poisoning. 4. Xerostomia (dry mouth) after radiotherapy. |
| ADRs | Burning pain, conjunctival hyperaemia, excessive sweating, salivation, bronchospasm, bradycardia, hypotension, diarrhoea |
| Special formulation | Pilocarpine Ocusert โ slow-release device placed in conjunctival sac for sustained IOP control |
| Feature | Detail |
|---|---|
| Mechanism | Competitive M3 antagonist. Blocks (1) Sphincter pupillae โ CANNOT contract โ passive MYDRIASIS; (2) Ciliary muscle โ CANNOT contract โ CYCLOPLEGIA |
| Duration | 7โ14 days โ very long, not ideal for routine examination |
| IOP effect | RAISES IOP โ mydriasis narrows iridocorneal angle โ obstructs aqueous outflow. CONTRAINDICATED in glaucoma. |
| Clinical uses | Refraction in children (cycloplegia needed). Uveitis/iritis. Pre-anaesthetic. Antidote for organophosphate poisoning. |
| ADRs | Dry mouth, blurred vision, urinary retention, tachycardia, constipation, raised IOP |
Three key volunteer experiments โ design, parameters, and expected results
| Parameter | Detail |
|---|---|
| Aim | Evaluate effect of Tropicamide 1% on pupillary diameter and accommodation reflex |
| Subjects | Healthy adults 18โ45 years, either sex, written informed consent |
| Design | Self-control: right eye = test (Tropicamide); left eye = control (untreated) |
| Exclusion criteria | Glaucoma, BPH, cardiovascular disease, anticholinergic use in past 7 days, soft contact lens wearers |
| Parameters | 1. Pupillary diameter (pupillometer). 2. Accommodation (ability to read fine print) |
| Recording times | Baseline, 5, 10, 15, 30 min; then 1, 2, 3, 4, 5, 6 hours |
| Expected results | Pupil dilation maximal at 1 hour. Accommodation lost (cycloplegia โ cannot read fine print). Duration: 4โ8 hours. Deeply pigmented iris requires more doses. |
| Statistics | Mean ยฑ SD. Compared by unpaired 't' test |
| Parameter | Detail |
|---|---|
| Design | Self-control: one eye test, other eye control |
| Parameters | 1. Pupillary diameter. 2. Near vision. 3. Distant vision. 4. Heart rate, BP (systemic ADRs). 5. Salivation |
| Recording times | Baseline, every 5 min up to 55 min; then 1, 1.5, 2, 4, 8 hours |
| Expected results | Miosis begins at 10 min. Near vision IMPROVES. Distant vision BLURRED. Conjunctival hyperaemia at 5 min. Possible sweating, salivation (systemic cholinergic effects). |
| Parameter | Detail |
|---|---|
| Design | Randomised single-blind: volunteers receive 10 mg hyoscine or placebo |
| Salivation measurement | 1 g rock salt under tongue for 1 minute โ saliva collected in measuring cylinder โ volume measured |
| Recording times | Baseline, 0.5, 1, 1.5, 2, 3, 4, 5, 6 hours |
| Expected results | Pupil dilates. Salivation DECREASES (dry mouth). Heart rate INCREASES. Maximum effect at ~3 hours. Returns to baseline by 6 hours. |
| ADRs to watch | Dry mouth, blurred vision, flushing, hallucinations, difficulty urinating, photosensitivity |
Used in every miotic/mydriatic experiment โ what it is and how to use it
| Type | Details |
|---|---|
| Simple Pupillometer | Stiff paper with parallel holes of increasing size: 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8 mm (half-inch gap between pairs) |
| How to use it | Volunteer looks at a well-illuminated distant object. Pupillometer held near eye with other eye closed. Volunteer looks through the holes appearing as circles. Size where two circles JUST START OVERLAPPING = pupillary diameter. |
| Animal use (Rabbit) | Scale-like instrument with holes: 0.5, 1, 1.5, 2, 2.5, 3 mm. Held against the eye and compared to pupil size. |
| Electronic Pupillometer | Measures pupil size, reaction speed, and light reactivity. Used in neurological assessment, brain injury monitoring, drug/alcohol detection. |
| Clinical significance | Neurological assessment, drug/alcohol detection, traumatic brain injury monitoring, pharmacological studies |
Most important clinical use of miotics โ types, mechanisms, drug groups
Types of Glaucoma
| Type | Description & Treatment |
|---|---|
| Primary Open-Angle Glaucoma (POAG) | Iridocorneal angle is OPEN but increased resistance in trabecular meshwork. Aqueous cannot drain. Most common. Treated with Pilocarpine, Timolol, Dorzolamide, Latanoprost. |
| Primary Angle-Closure Glaucoma (PACG) | Iris BLOCKS access to outflow channels. Sudden severe IOP rise. Emergency. Treated urgently with Pilocarpine (constricts pupil โ pulls iris away from angle โ opens drainage). AVOID mydriatics! |
| Drug Class | Examples | Mechanism |
|---|---|---|
| Cholinergic agonists | Pilocarpine, Carbachol, Physostigmine | โ aqueous outflow โ โ IOP |
| Adrenergic agonists | Epinephrine, Brimonidine | โ aqueous production |
| ฮฒ-Adrenergic blockers | Timolol, Levobunolol, Betaxolol | Block ฮฒ receptors on ciliary epithelium โ โ aqueous production |
| Prostaglandin analogues | Latanoprost, Travoprost, Bimatoprost | โ uveoscleral outflow (alternative drainage route) |
| Carbonic anhydrase inhibitors (topical) | Dorzolamide, Brinzolamide | Inhibit aqueous production |
| Carbonic anhydrase inhibitors (systemic) | Acetazolamide, Methazolamide | โ aqueous production |
| Hyperosmotic agents | Glycerol, Mannitol | Draw fluid from eye osmotically โ acute emergencies |
All drugs at a glance + 12 top exam facts + mnemonics
| Drug | Class | Pupil | Light Reflex | Corneal Reflex | Key Clinical Point |
|---|---|---|---|---|---|
| Pilocarpine | Direct M3 agonist | Constricts | Present | Present | Treats glaucoma (both types). Improves near vision. Onset 10 min. |
| Physostigmine | Anticholinesterase | Constricts | Present | Present | Indirect miotic. Inhibits AChE. |
| Atropine | M3 antagonist | Dilates | ABSENT | Present | Cycloplegia + mydriasis. Contraindicated in glaucoma. 7โ14 days. |
| Tropicamide | Short M3 antagonist | Dilates | ABSENT | Present | 4โ8h. Preferred for fundoscopy/refraction. |
| Hyoscine | M1 antagonist | Dilates | ABSENT | Present | Also โ salivation, โ HR. Max at 3 h. |
| Phenylephrine | Direct ฮฑ1 agonist | Dilates | Present | Present | ACTIVE mydriasis. No cycloplegia. Safe for fundoscopy. |
| Ephedrine | Indirect sympathom. | Dilates | Present | Present | Active mydriasis. Releases stored NA. |
| Cocaine | NA reuptake blocker + LA | Dilates | Present | ABSENT | UNIQUE: Mydriasis + loss of corneal reflex. |
| Morphine (topical) | Opioid | No effect | No effect | No effect | NOT absorbed topically. IV โ PINPOINT pupils via Edinger-Westphal. |
| Timolol | ฮฒ-blocker | No change | Normal | Normal | โ aqueous production โ โ IOP. Used in glaucoma. |
Top 12 High-Yield Facts